Loading...
| A02980 | Pages: NA | Aug 2021 | 4199 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Hydroxytryptamine Receptor Market
Request Now !Hydroxytryptamine receptors are a group of G-protein coupled receptors and ligand gated ion channels, which are found in the peripheral and central nervous system. These receptors influence various biological and neurological processes such as aggression, anxiety, learning, mood, nausea, sleep, and cognition.
Due to the unique properties, hydroxytryptamine receptors are used in a variety of drugs such as antidepressants, antipsychotics, antimigraine agents, hallucinogens, and entactogens. This factor drives the growth of the market. However, prolonged use of 5-HT receptor drugs may cause mental disorders with complex etiologies, which impede the market.
The global hydroxytryptamine receptors market is segmented based on product type, applications, and geography. Based on product type, the market is classified into HTR6, HTR2B, and others. Further, based on application, it is divided into attention deficit hyperactivity disorder, psychiatric disorders, Alzheimers disease, chronic obstructive pulmonary disease (COPD), and memory impairment. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive competitive analysis and profiles of major market players such as Adamed, Avineuro Pharmaceutical, Axovant Sciences, Biotie Therapies, Celon Pharma, Galenea Corp, H. Lundbeck, Reviva Pharmaceuticals, Suven Life Sciences, and Teva Pharmaceutical Industries Ltd. are also provided in this report.
Key Benefits:
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 HYDROXYTRYPTAMINE RECEPTOR MARKET, BY PRODUCT TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. HTR6
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. HTR2B
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. OTHERS
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
CHAPTER 5 HYDROXYTRYPTAMINE RECEPTOR MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. ATTENTION DEFICIT HYPERACTIVITY DISORDER
5.2.1. Market size and forecast
5.3. PSYCHIATRIC DISORDERS
5.3.1. Market size and forecast
5.4. ALZHEIMER'S DISEASE
5.4.1. Market size and forecast
5.5. CHRONIC OBSTRUCTIVE PULMONARY DISEASE
5.5.1. Market size and forecast
5.6. MEMORY IMPAIRMENT
5.6.1. Market size and forecast
CHAPTER 6 HYDROXYTRYPTAMINE RECEPTOR MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America Hydroxytryptamine Receptor Market by Product Type
6.2.5. North America Hydroxytryptamine Receptor Market by Applications
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Spain market size and forecast
6.3.3.5. Rest of Europe market size and forecast
6.3.4. Europe Hydroxytryptamine Receptor Market by Product Type
6.3.5. Europe Hydroxytryptamine Receptor Market by Applications
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific Hydroxytryptamine Receptor Market by Product Type
6.4.5. Asia-Pacific Hydroxytryptamine Receptor Market by Applications
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast
6.5.4. LAMEA Hydroxytryptamine Receptor Market by Product Type
6.5.5. LAMEA Hydroxytryptamine Receptor Market by Applications
CHAPTER 7 COMPANY PROFILES
7.1. ADAMED
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. AVINEURO PHARMACEUTICAL
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. AXOVANT SCIENCES
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. BIOTIE THERAPIES
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. CELON PHARMA
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. GALENEA CORP
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. H. LUNDBECK
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. REVIVA PHARMACEUTICALS
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. SUVEN LIFE SCIENCES
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. H TEVA PHARMACEUTICAL INDUSTRIES LTD.
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
